Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 285.50
Bid: 281.00
Ask: 282.00
Change: -2.50 (-0.87%)
Spread: 1.00 (0.356%)
Open: 286.50
High: 289.50
Low: 280.50
Prev. Close: 288.00
MAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 Mitchells & Butlers Plc

19 Sep 2011 12:00

RNS Number : 4840O
Nomura International PLC (EPT)
19 September 2011
 



FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nomura International Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mitchells & Butlers Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mitchells & Butlers Plc

(d) Date position held/dealing undertaken:

16 September 2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

8 13/24p ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

184,970

0.045%

121,578

0.030%

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

184,970

0.045%

121,578

0.030%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary Shares

Purchase

483

2.591

Ordinary Shares

Purchase

1,644

2.593

Ordinary Shares

Purchase

740

2.596

Ordinary Shares

Purchase

557

2.599

Ordinary Shares

Purchase

60

2.600

Ordinary Shares

Purchase

10,894

2.601

Ordinary Shares

Purchase

372

2.603

Ordinary Shares

Purchase

744

2.604

Ordinary Shares

Purchase

8,861

2.604

Ordinary Shares

Purchase

4,013

2.605

Ordinary Shares

Purchase

2,692

2.606

Ordinary Shares

Purchase

1,112

2.607

Ordinary Shares

Purchase

2,285

2.608

Ordinary Shares

Purchase

3,192

2.609

Ordinary Shares

Purchase

33,422

2.610

Ordinary Shares

Purchase

3,519

2.611

Ordinary Shares

Purchase

1,077

2.612

Ordinary Shares

Purchase

707

2.613

Ordinary Shares

Purchase

205

2.614

Ordinary Shares

Purchase

1,759

2.620

Ordinary Shares

Purchase

734

2.621

Ordinary Shares

Purchase

243

2.622

Ordinary Shares

Purchase

2,434

2.624

Ordinary Shares

Purchase

4,301

2.626

Ordinary Shares

Purchase

206

2.627

Ordinary Shares

Purchase

1,596

2.628

Ordinary Shares

Purchase

646

2.629

Ordinary Shares

Purchase

2,257

2.630

Ordinary Shares

Purchase

1,244

2.632

Ordinary Shares

Purchase

758

2.633

Ordinary Shares

Purchase

6,033

2.635

Ordinary Shares

Purchase

2,449

2.636

Ordinary Shares

Purchase

1,063

2.637

Ordinary Shares

Purchase

1,880

2.639

Ordinary Shares

Purchase

8,225

2.640

Ordinary Shares

Purchase

2,256

2.641

Ordinary Shares

Purchase

2,479

2.642

Ordinary Shares

Purchase

3,229

2.643

Ordinary Shares

Purchase

13,662

2.644

Ordinary Shares

Purchase

15,293

2.645

Ordinary Shares

Purchase

6,565

2.646

Ordinary Shares

Purchase

7,664

2.646

Ordinary Shares

Purchase

4,994

2.647

Ordinary Shares

Purchase

7,937

2.648

Ordinary Shares

Purchase

6,860

2.649

Ordinary Shares

Purchase

24,001

2.650

Ordinary Shares

Purchase

3,146

2.651

Ordinary Shares

Purchase

4,031

2.652

Ordinary Shares

Purchase

196

2.653

Ordinary Shares

Purchase

1,203

2.654

Ordinary Shares

Purchase

10,066

2.655

Ordinary Shares

Purchase

199

2.657

Ordinary Shares

Purchase

468

2.658

Ordinary Shares

Purchase

2,337

2.660

Ordinary Shares

Purchase

289

2.662

Ordinary Shares

Purchase

107

2.670

Ordinary Shares

Purchase

285

2.672

Ordinary Shares

Purchase

124

2.675

Ordinary Shares

Purchase

1,719

2.684

Ordinary Shares

Purchase

299

2.686

Ordinary Shares

Purchase

558

2.687

Ordinary Shares

Purchase

1,325

2.688

Ordinary Shares

Purchase

468

2.692

Ordinary Shares

Purchase

1,204

2.695

Ordinary Shares

Purchase

1,174

2.696

Ordinary Shares

Purchase

197

2.697

Ordinary Shares

Purchase

755

2.700

Ordinary Shares

Sale

609

2.598

Ordinary Shares

Sale

9,185

2.600

Ordinary Shares

Sale

4,383

2.602

Ordinary Shares

Sale

12,110

2.604

Ordinary Shares

Sale

201

2.605

Ordinary Shares

Sale

1,152

2.606

Ordinary Shares

Sale

4,319

2.607

Ordinary Shares

Sale

1,962

2.608

Ordinary Shares

Sale

13,250

2.609

Ordinary Shares

Sale

8,881

2.610

Ordinary Shares

Sale

2,037

2.611

Ordinary Shares

Sale

1,860

2.612

Ordinary Shares

Sale

363

2.613

Ordinary Shares

Sale

1,296

2.616

Ordinary Shares

Sale

595

2.618

Ordinary Shares

Sale

2,429

2.622

Ordinary Shares

Sale

192

2.623

Ordinary Shares

Sale

30,583

2.624

Ordinary Shares

Sale

338

2.625

Ordinary Shares

Sale

3,113

2.626

Ordinary Shares

Sale

1,215

2.627

Ordinary Shares

Sale

500

2.628

Ordinary Shares

Sale

1,200

2.630

Ordinary Shares

Sale

2,180

2.632

Ordinary Shares

Sale

300

2.634

Ordinary Shares

Sale

616

2.635

Ordinary Shares

Sale

1,790

2.636

Ordinary Shares

Sale

1,190

2.637

Ordinary Shares

Sale

4,753

2.638

Ordinary Shares

Sale

1,783

2.639

Ordinary Shares

Sale

13,818

2.640

Ordinary Shares

Sale

3,492

2.641

Ordinary Shares

Sale

2,994

2.642

Ordinary Shares

Sale

5,420

2.643

Ordinary Shares

Sale

2,077

2.644

Ordinary Shares

Sale

5,575

2.645

Ordinary Shares

Sale

651

2.646

Ordinary Shares

Sale

746

2.647

Ordinary Shares

Sale

7,266

2.648

Ordinary Shares

Sale

10,593

2.649

Ordinary Shares

Sale

7,995

2.650

Ordinary Shares

Sale

1,238

2.651

Ordinary Shares

Sale

2,514

2.652

Ordinary Shares

Sale

3,639

2.653

Ordinary Shares

Sale

1,874

2.654

Ordinary Shares

Sale

2,168

2.655

Ordinary Shares

Sale

610

2.656

Ordinary Shares

Sale

773

2.657

Ordinary Shares

Sale

1,201

2.659

Ordinary Shares

Sale

485

2.661

Ordinary Shares

Sale

172

2.662

Ordinary Shares

Sale

1,266

2.663

Ordinary Shares

Sale

502

2.667

Ordinary Shares

Sale

598

2.668

Ordinary Shares

Sale

440

2.669

Ordinary Shares

Sale

500

2.671

Ordinary Shares

Sale

250

2.675

Ordinary Shares

Sale

1,569

2.681

Ordinary Shares

Sale

773

2.685

Ordinary Shares

Sale

1,528

2.686

Ordinary Shares

Sale

1,287

2.687

Ordinary Shares

Sale

580

2.689

Ordinary Shares

Sale

673

2.695

Ordinary Shares

Sale

2,244

2.696

Ordinary Shares

Sale

993

2.697

Ordinary Shares

Sale

1,298

2.699

Ordinary Shares

Sale

500

2.700

Ordinary Shares

Sale

500

2.702

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

19 September 2011

Contact name:

Kyere Tabiri

Telephone number:

020 7102 1267

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEODKCDPKBKDOCD
Date   Source Headline
12th Mar 201812:30 pmRNSChange to Director's Details - Stewart Gilliland
28th Feb 201811:15 amRNSTotal Voting Rights
12th Feb 20183:15 pmRNSDirector/PDMR Shareholding
8th Feb 20183:31 pmRNSDirector/PDMR Shareholding
8th Feb 201810:45 amRNSHolding(s) in Company
8th Feb 201810:26 amRNSDirector/PDMR Shareholding
7th Feb 20183:36 pmRNSDirector/PDMR Shareholding
6th Feb 20189:45 amRNSTotal Voting Rights
31st Jan 201812:30 pmRNSTotal Voting Rights
29th Jan 20183:30 pmRNSAdditional Listing
24th Jan 201810:30 amRNSResult of Annual General Meeting
15th Jan 20183:54 pmRNSDirector/PDMR Shareholding
12th Jan 20187:00 amRNSFirst Quarter Trading Update
10th Jan 20182:00 pmRNSNotice of first quarter trading update
2nd Jan 201811:50 amRNSTotal Voting Rights
21st Dec 201712:07 pmRNSAnnouncement of Scrip Reference Share Price
18th Dec 201711:19 amRNSDirector/PDMR Shareholding
14th Dec 201712:00 pmRNSAnnual Report 2017
11th Dec 201712:08 pmRNSDirector/PDMR Shareholding
30th Nov 20173:57 pmRNSTotal Voting Rights
30th Nov 201711:00 amRNSShort-Term Deferred Incentive Plan
23rd Nov 20177:00 amRNSFULL YEAR RESULTS
20th Nov 20172:45 pmRNSDirector/PDMR Shareholding
15th Nov 20172:00 pmRNSNotice of Final Results
31st Oct 20172:30 pmRNSTotal Voting Rights
23rd Oct 20173:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20173:00 pmRNSBlock listing Interim Review
29th Sep 201710:30 amRNSTotal Voting Rights
25th Sep 20173:00 pmRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSPre-Close Trading Update
15th Sep 201711:00 amRNSNotice of Pre-Close Trading Statement
31st Aug 20172:27 pmRNSTotal Voting Rights
29th Aug 201711:15 amRNSDirector/PDMR Shareholding
17th Aug 201712:30 pmRNSHolding(s) in Company
17th Aug 201712:00 pmRNSHolding(s) in Company
31st Jul 201712:19 pmRNSDirector/PDMR Shareholding
31st Jul 201710:30 amRNSTotal Voting Rights
27th Jul 20177:00 amRNSThird Quarter Trading Update
24th Jul 201711:00 amRNSNotice of Third Quarter Trading Update
12th Jul 20172:00 pmRNSAdditional Listing
7th Jul 20172:30 pmRNSDirector/PDMR Shareholding
4th Jul 20174:00 pmRNSDirector/PDMR Shareholding
3rd Jul 20173:29 pmRNSDirector/PDMR Shareholding
30th Jun 20172:30 pmRNSTotal Voting Rights
27th Jun 20172:00 pmRNSAdditional Listing
27th Jun 201710:30 amRNSDirector/PDMR Shareholding
22nd Jun 20173:59 pmRNSHolding(s) in Company
22nd Jun 20172:45 pmRNSDirector/PDMR Shareholding
22nd Jun 20172:45 pmRNSDirector/PDMR Shareholding
9th Jun 20173:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.